ConductScience.org, home

Paper20142295

Effect of needle length when immunizing obese adolescents with hepatitis B vaccine.

Middleman AB and 2 others. Pediatrics, 2010. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Effect of needle length when immunizing obese adolescents with hepatitis B vaccine. Papers, record 20142295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20142295

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of needle length when immunizing obese adolescents with hepatitis B vaccine.
PubMed
Journal
Pediatrics
PubMed
Year
2010
PubMed
Publication types
Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2015-04-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Middleman ABAmy B
2Anding RRoberta
3Tung CCelestine

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis B AntibodiesMajor topic
Hepatitis B VaccinesMajor topic
NeedlesMajor topic
ObesityMajor topic
Adolescent
Equipment Design
Female
Humans
Male
Young Adult

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
39204057Investigation of the Hepatitis-B Vaccine's Immune Response in a Non-Alcoholic Fatty Liver Disease Mouse Model.Vaccines (Basel)2024https://conductscience.org/library/papers/39204057PubMed
38827254Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian Adolescents.Adv Virol2024https://conductscience.org/library/papers/38827254PubMed
36669836What variables should inform needle length choice for deltoid intramuscular injection? A systematic review.BMJ Open2023https://conductscience.org/library/papers/36669836PubMed
36619617Effectiveness and safety of tetanus vaccine administration by intramuscular vs. subcutaneous route in anticoagulated patients: Randomized clinical trial in primary care.Front Med (Lausanne)2022https://conductscience.org/library/papers/36619617PubMed
36536872COVID-19 vaccination and the skin to deltoid MUSCLE distance in adults with diabetes.Vaccine X2023https://conductscience.org/library/papers/36536872PubMed
36298453Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing Toxoplasma gondii Rhoptry Protein 18.Vaccines (Basel)2022https://conductscience.org/library/papers/36298453PubMed
35891316Body Mass Index and Antibody Persistence after Measles, Mumps, Rubella and Hepatitis B Vaccinations.Vaccines (Basel)2022https://conductscience.org/library/papers/35891316PubMed
35792021The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccine.Vaccine2022https://conductscience.org/library/papers/35792021PubMed
34794822A long shot: The importance of needle length in vaccinating patients with obesity against COVID-19.Vaccine2022https://conductscience.org/library/papers/34794822PubMed
33628754A comparison of post vaccination hepatitis B surface antibody level on the large and appropriate for gestational age infants.Clin Exp Vaccine Res2021https://conductscience.org/library/papers/33628754PubMed
33431890Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD).NPJ Vaccines2021https://conductscience.org/library/papers/33431890PubMed
32355503The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route.Immun Ageing2020https://conductscience.org/library/papers/32355503PubMed
30091147Needle size for vaccination procedures in children and adolescents.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/30091147PubMed
26658380Influenza Vaccine is Protective Against Laboratory-confirmed Influenza in Obese Children.Pediatr Infect Dis J2016https://conductscience.org/library/papers/26658380PubMed
26313239Effect of vaccine administration modality on immunogenicity and efficacy.Expert Rev Vaccines2015https://conductscience.org/library/papers/26313239PubMed
26163925The weight of obesity on the human immune response to vaccination.Vaccine2015https://conductscience.org/library/papers/26163925PubMed
26140085Induced immunity against hepatitis B virus.World J Hepatol2015https://conductscience.org/library/papers/26140085PubMed
25076128In a safety net population HPV4 vaccine adherence worsens as BMI increases.PLoS One2014https://conductscience.org/library/papers/25076128PubMed
24349359Is obesity a risk factor for vaccine non-responsiveness?PLoS One2013https://conductscience.org/library/papers/24349359PubMed
23173138Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature.Diabetes Care2012https://conductscience.org/library/papers/23173138PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20142295

GET https://conductscience.org/api/papers/v1/20142295/cited_by?page=2